• Aurobindo, Sandoz call off $900 million deal expresspharma
    April 03, 2020
    In September 2018, Aurobindo Pharma had said its US subsidiary has entered into a pact to acquire commercial operations and three manufacturing facilities in America from Sandoz Inc.
PharmaSources Customer Service